The Diagnostics segment focuses on developing, manufacturing, and distributing diagnostic test kits and related products. Research and development efforts are centered on creating innovative testing platforms, including real-time PCR (Revogene), isothermal DNA amplification (Alethia), lateral flow immunoassay (Curian), rapid immunoassay (ImmunoCard), enzyme-linked immunoassays (PREMIER), and breath tests (BreathID/BreathTek). These technologies are applied to detect gastrointestinal and respiratory infectious diseases, as well as blood lead levels. The segment's products are sold directly and through distributors to hospitals, laboratories, and clinics, impacting patient care through accurate and timely diagnoses. Meridian's market position is strengthened by its diverse product portfolio and established distribution network. Future opportunities include expanding the test menu and exploring new diagnostic technologies. Regulatory compliance and clinical validation are critical aspects of this segment, ensuring the safety and efficacy of diagnostic tests. Partnerships with other diagnostic companies are also key to expanding market reach and product offerings.

The Life Science segment provides raw materials and reagents for in vitro diagnostic manufacturers and researchers. This segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents. Research and development activities focus on improving the quality and performance of these reagents, as well as expanding the product portfolio to meet the evolving needs of the diagnostic and research communities. The segment's technologies and methodologies include protein purification, antibody production, and nucleic acid amplification. These products are used in immunological and molecular tests for human, animal, plant, and environmental applications. The patient impact is indirect, as these reagents enable the development of diagnostic tests and research that ultimately improve patient outcomes. Meridian's market position is strong due to its high-quality products and established relationships with key customers. Future opportunities include expanding into new research areas and developing innovative reagents. Regulatory compliance and quality assurance are essential to ensure the reliability and safety of the products. Partnerships with research institutions and diagnostic companies are crucial for driving innovation and market expansion.